Silent myocardial ischemia: some good news.
Killip
T
T
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001262:Atenolol / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D004110:Diltiazem / Q000627:therapeutic use; D004562:Electrocardiography; D005080:Exercise Test; D006801:Humans; D007548:Isosorbide Dinitrate / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control; D017202:Myocardial Ischemia / Q000175:diagnosis* / Q000209:etiology / Q000401:mortality; D009204:Myocardial Revascularization; D009543:Nifedipine / Q000627:therapeutic use; D010865:Pilot Projects; D016032:Randomized Controlled Trials as Topic / Q000379:methods / Q000592:standards; D012107:Research Design; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D014665:Vasodilator Agents; D001262:Atenolol; D004110:Diltiazem; D009543:Nifedipine; D007548:Isosorbide Dinitrate